For decades, technology has relentlessly made phones, laptops,    apps and entire industries cheaper and betterwhile health care    has stubbornly loitered in an alternate universe where tech    makes everything more expensive and more complex.  
    Now startups are applying artificial intelligence (AI), floods    of data and automation in ways that promise to dramatically    drive down the costs of health care while increasing    effectiveness. If this profound trend plays out, within five to    10 years, Congress wont have to fight about the exploding    costs of Medicaid and insurance. Instead, it might battle over    what to do with a massive windfall. Todays debate over the    repeal of Obamacare would come to seem as backward as a    discussion about the merits of leeching.  
        Subscribe to Newsweek from $1 per    week  
    Hard to believe? One proof point is in the maelstrom of    activity around diabetes, the most expensive disease in the    world. In the U.S., nearly 10 percent of the population has    diabetes, around 30 million people. Within a decade, some    experts say, the number of diabetics in China will outnumber    the entire U.S. population. Most people who suffer from the    disease spend $5,000 to $10,000 a year on medication, and    diabetics with complications can spend hundreds of thousands of    dollars on doctor and hospital bills. That and the lost wages    of diabetics cost the U.S. alone more than $245 billion a year,    according to the Centers for    Disease Control and Prevention.  
    Thats an enormous problem to solve  and a pile of potential    cash and customers to be wonwhich is why diabetes is    attracting entrepreneurs like ants to a dropped ice cream cone.    One of those entrepreneurs is SamiInkinen. He was a    co-founder of the real estate site Trulia and has long been an    endurance athlete, competing seriously in triathlons and    Ironman events. In 2014, he and his wife rowed from California    to Hawaii. None of this fits the typical profile of a diabetic,    yet in 2011, soon after yet another triathlon, Inkinen was    diagnosed with Type 2 diabetes. And like many driven,    super-smart data geeks, he dove into research to understand    everything about his condition.  
            Soila    Solano injects herself with insulin at her home in Las Vegas on    April 18. Solano was diagnosed with Type 2 diabetes six years    ago. Nearly 10 percent of the U.S. population has diabetes, the    most expensive disease in the world. John    Locher/AP  
    That journey led him to Dr. Stephen Phinney, a medical    researcher at the University of California, Davis, and Jeff    Volek, a scientist at Ohio State. Phinney and Volek wrote two books together about    low-carbohydrate diets and published scientific papers    describing how constant adjustments to diet and lifestyle can    reverse diabetes in many patients. Diabetes is almost never    treated that way because the program is too hard for most    people to stick to. It requires so much coaching and scrutiny    by medical professionals, youd pretty much have to hire a    live-in doctor.  
    Inkinen convinced Phinney and Volek that technology could    essentially re-create a live-in doctor and diabetes coach in a    smartphone. Together, the three founded Virta Health in 2014.    The company stayed in stealth mode until now, launching in March. It felt    like a duty to do this, Inkinen tells Newsweek .    Here is an epidemic of epic proportion, and nothing is    working. We can combine science and technology to solve the    problem at much lower cost and do it safely.  
    Heres how Virta works and why its approach is so important to    the future of health care. On the front end, Virta is software    on a smartphone. Diabetics who sign up agree to regularly enter    data: glucose levels, weight, blood pressure, activity. Some do    this by manually entering information; others use devices like    a Fitbit or connected scales to automatically send it in. The    app also frequently asks multiple-choice questions about mood,    energy levels and hunger  more data that the AI software    crunches to learn about the patient, look for warning signs and    symptoms and guide Virtas doctors.  
    On the back end, Virta hires doctors who get streams of updates    from Virtas software and use the data to help them make    decisions about how to adjust each patients diet and    medications or anything else that might affect that persons    health. Any clinical decision is always made by a doctor,    Inkinen says. But the software increases productivity by    10-X. (Thats 10 times, in Silicon Valleyspeak.) When all    this works and the patient follows the programs strict dietary    and medical controls, diabetes can be reversed, clinical trials    of Virtas system have shown. Around 87 percent of    patients who had been relying on insulin to control their    condition either decreased their dose or eliminated their use    of insulin completelya success rate that matches that for    bariatric surgery, which is an expensive, invasive, last-ditch    effort for severe diabetics.  
    Virta leverages AI software, smartphones and cloud computing to    allow its doctors to continually interact with many times more    patients than they can in a clinic or hospital, and it gives    its diabetic patients a cross between a pocket doctor and a    guardian angel. The result is a promising treatment for    diabetes that could get many sufferers off medication and keep    them out of doctors offices and hospital emergency rooms. And    that, in turn, would greatly lower the overall cost of    diabetes.  
    Virta is just one startup of many attacking diabetes. Livongo is a more automated but less    doctor-oriented version of Virtas program. The company, which    raised $52.5 million in March, makes a wireless glucose-reading    device that uploads the diabetics data. AI software learns    about the patient and sends a stream of tips and information    intended to help the diabetic manage the disease and stay out    of hospitals. Yet another new startup, Fractyl, takes a more medical approach. It    invented a type of catheter that seems to cause changes in the    intestines that result in reversing diabetes.  
    Startup tracker Crunchbase lists about 130 new    tech-oriented companies (the number changes constantly)    involved in some aspect of diabetes. While many of these    startups will fail, its hard to imagine that some wont have a    significant impact.  
    These efforts matter to all of us because diabetes is such an    enormous drain on health care resources. Venture capitalist    Hemant Taneja, who helped start Livongo, says technology could    take $100 billion out of the annual cost of diabetes in the    U.S. Imagine if even 20 percent of diabetics could get off    medication and have little need for a doctors care. All of    those medical resources would get freed up for other patients    and other conditions, which should help lower prices of health    care for all. If we want to massively lower health care costs,    we need to figure out how to address metabolic health issues    [like diabetes] at their core, Inkinen says. I would bet my    house that in 15 years, the future health care company looks    like what were doing todaynot treating diseases at the end of    the road but catching them along the way and reversing them.  
            A user    checks blood glucose with the Livongo system.    Livongo  
    Over the past decade, medical records in the U.S.long kept on    paper in doctors horrible handwritinghave been digitized and    fed into software. That hasnt helped lower health care costs    yet, and in fact it is adding to them as systems get installed    and medical professionals learn to use software that can be    clunky. Epic Systems, the biggest electronic medical records    company, handles 54 percent of patients records in the U.S.    but gets bad marks for being so hard to use that it eats up    doctors and nurses time. One report from Beckers    Hospital Review said that almost 30 percent of Epic    clients wouldnt recommend it to their peers. A survey by Black Book Market    Research found that 30 percent of hospital personnel were    dissatisfied with their EMR systems, with Epic getting the    strongest dissatisfaction.  
    But theres a larger gain from the pain of EMRs: Enormous    amounts of medical information are now digitized. As more    medical interaction happens onlineas with Virta or Livongothe    more kinds of data well collect. Internet of Things devices,    whether Fitbits or connected glucose meters or potential new    devices like Apple AirPods that take biometric    readings, will add yet more data. All this data can help AI    software learn about diseases in general, and about individual    patients, opening up new ways for technology to be applied.  
    Some of the new applications of AI will simply improve a    tragically inefficient health care industry. Qventus is a startup using AI to take all the data    flowing through a hospital to learn how to free up doctors and    nurses to see more patients and improve outcomes. Were    creating efficiency out of seemingly nothing, Qventus CEO    Mudit Garg tells me. Two years ago, work like this was so    unsexy. But this is where the rubber meets the road.  
    One of his clients, Mercy Hospital Fort Smith in Fort Smith,    Arkansas, has been able to treat 3,000 more patients a year    with the same resources, an increase of 18 percent. Here again,    technology is increasing the supply of medical services,    potentially changing the cost equation that keeps forcing    health care prices higher.  
    AI is also starting to automate some of the work of doctors.    IBMs Watson, which uses machine learning and massive computing    power to reason its way through questions, is on its way to    becoming the best diagnostician on the planet. Its software can    soak up all manner of available (and anonymized) patient data,    plus the tens of thousands of medical research papers published every year (far    more than any human could read). The system can even keep up    with the news, learning, for instance, which regions are    affected by a certain contagious disease, which might help    diagnose someone who recently traveled to one of those areas.    By asking patients a series of questions spoken into any kind    of computer or connected device, Watson can quickly narrow down    the possible causes of a medical problem. Today, IBM works on    test projects with major hospitals like the Cleveland Clinic to    put Watson in the hands of doctors, who are learning how to use    the technology like a brilliant assistant.  
    But the day will come when Watson or something like it is    available to everyone through a smartphone or some other    device. Amazon is starting down that path by    partnering with HealthTap to offer what it calls Dr. A.I. on    Alexa, Amazons voice-activated AI gadget for consumers. Its    not nearly as robust as Watson but works on the same idea. Just    tell it your medical problem, and it will ask you questions to    help narrow down what it might be.  
            A clerk    works in the medical records department at Clinica Sierra    Vista's East Bakersfield Community Health Center in    Bakersfield, California on October 20, 2009. As medical records    increasingly become digitized, their data will help AI learn    more about diseases and how to help patients.    Phil    McCarten/Reuters  
    As health care AI develops, startups are also creating new    kinds of genomics-based medicine. Just 16 years ago, the    Human Genome Project and    geneticist Craig Venters startup, Celera Genomics, published    the results of their human genome sequencing within a day of    each other in 2001. Venter said his project took 20,000 hours    of processor time on a supercomputer. This year, startup Color    Genomics is offering a $249 genetic test that can sequence most    of the pertinent genes in the human body. Colors goal is to    make genetic sequencing so cheap and easy that every baby born    will have it done, and the data will inform his or her health    care for life.  
    Combine genetic data about a person with all the kinds of data    Watson can ingest, and were close to being able to build AI    software that can at least supplant that first visit to a    doctor when youre sickwhich, of course, is when you least    want to travel to a doctors office. Instead, people will    increasingly speak to a smartphone or to something like Dr.    A.I. on Alexa about their health problems and, if necessary,    send in photos of that rash or funky toe. If the system has    your health care records and genetic data, it can gain more    insight into your condition than any doctor operating on an    informed hunch.  
            An early    prototype of Watson in Yorktown Heights, NY. The cognitive    computing system was originally the size of a master bedroom in    2011. Clockready  
    On many occasions, the app might tell the user the problem is    nothing seriousa robot equivalent of Take two aspirin and    call me in the morning. Other times, the app might send the    user to a clinic to get a test or X-ray. If thats how it plays    out, a large chunk of the traffic into doctors offices and    hospitals will fade away.  
    Add it up, and in these next few years were going to see a    parade of tech applications that reduce demand on the health    care system while giving all of us more access to care. Doctors    should be freed up to do a better job for patients who truly    need their attention. Theoretically, all of this will help keep    more people healthier. And if were all healthier and using    health care less, the laws of supply and demand should kick in,    sending the overall cost of health care tumbling.  
    However, there are bumps ahead because, as our erudite    president recently said, nobody knew that health care could be    so complicated.  
    The economics of health care are weird. First of all, the usual    forces dont apply to highly regulated industries, and health    care is perhaps the most regulated in the U.S. and around the    world because lives are at stake. In most countries, regulators    prevent AI software from crossing the line into independently    offering a diagnosis or clinical advicethats strictly the    purview of doctors. New medical devices, like Fractyls, have    to get approval from the Food and Drug Administration.    Lobbyists often slow regulatory change to maintain the status    quo and benefit incumbents charging inflated prices.  
    Personal health care decisions in the U.S. often get influenced    by insurance companies, employers who pay for health benefits,    and Medicare. Unlike most industries, consumers in health care    dont have much information about pricing or quality, so they    cant weigh options and make rational choices. Moreover, we    think about health differently from anything else we buy. Many    of us are never satiated with health carewe always want more    and better health care, if we can afford it. One study    published in March showed that telehealth making doctors    available by video callprompted people to seek care for minor    illnesses they otherwise wouldve ignored. Only 12 percent of    telehealth visits replaced in-person visits, and the other 88    percent was new demand.  
    Until recently, most new medical technology has been high-end    products that give doctors and hospitals a reason to charge    more for something that couldnt have been done in the past.    Think MRI machines or robotic limbs. These improve    quality of life but add to costs. In 2008, the Congressional    Budget Office concluded, The most important factor driving the    long-term growth of health care costs has been the emergence,    adoption, and widespread diffusion of new medical technologies    and services.  
            A doctor    and patient demonstrate how they use Virta for diabetes    monitoring and treatment. Virta Health  
    The next wave of health care technology is different. The    combination of data and AI was not available until the past    year or two, and it can lead to the kind of automation that has    disrupted so many other industries. Many health care    entrepreneurs are focused precisely on the win-win-win prospect    of lowering the cost of care while making it better and    available to more people. Of course, there will be challenges    to address, such as making sure our highly sensitive medical    data stays protected and private, even as it flies around    various networks and systems.  
    As startups bring these technologies online, theyre often    doing an end run around insurance companies, instead finding    demand among consumers or employers who offer health coverage.    Livongo, for instance, points out to companies that each    diabetic employee costs thousands of dollars a year in care.    Pay for the Livongo service, the pitch goes, and your company    will save money as those employees better manage their    conditions. By last year, Livongo had signed up more than 50    large customers, including Quicken, Office Depot, Office Max    and S.C. Johnson & Son.As the thinking goes among    health care startups, once employers and consumers embrace new    technology, insurance companies, regulators and health care    incumbents will have to follow.  
    As that happens, the technologists promise, economic forces    will finally stall or reverse the climbing cost of health care    in the U.S. and around the world, a development that would, if    were lucky, leave the president and just about every member of    Congress speechless.  
            Jon-Paul Pezzolo  
Excerpt from:
How Artificial Intelligence Will Cure America's Sick Health Care System - Newsweek